The Basics of Blister Packaging in Drug Trials
Blistering – a thin film that lets patients “pop” tablets out of a protective cavity – isn’t as common in clinical packaging as it used to be. The rise of biotech means more vials, syringes, and injectables at play in modern trials. Still, blistering is critical to the protection and integrity of many tablet-based clinical studies, and getting it right is key to trial success.
The Best Clinical RFPs We’ve Ever Seen
We see a ton of RFPs at Xerimis. At this point in our growth, we know what information a company needs to provide to determine if we’re a good fit for their trial. But RFPs are still a good way for us to get on the same page with a prospect, some of whom don’t have as much experience in the industry.
Where to Find Us This Fall
We have a full fourth quarter docket and will be making the global rounds. Below is a list of where you can find our team over the coming months.
Xerimis Expands BD Team
Xerimis is expanding its Business Development group due to increasing opportunities worldwide. This uptick of interest in Xerimis is due in part to the opening of its purpose-built, 13,000-square foot United Kingdom facility in 2016.
Cold Chain Logistics: Which System Is Right for You?
Choosing the right cold chain system is key to keeping trials on schedule and free of logistical headaches. Xerimis guides clients toward suggested logistical plans and helps you to understand how and why we land there.
Tom Brady Joins the Xerimis Team as Director of Business Development, North America
Xerimis Inc. is proud to announce that Tom Brady has been hired as Director of Business Development, North America. Tom will be responsible for working with sponsor companies throughout North America to satisfy their clinical supply needs.